This company listing is no longer active
Resumen de acción YGEN
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Yourgene Health Plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0052 |
| 52 Week High | UK£0.057 |
| 52 Week Low | UK£0.0019 |
| Beta | 0.86 |
| 1 Month Change | 5.10% |
| 3 Month Change | 139.53% |
| 1 Year Change | -90.89% |
| 3 Year Change | -97.04% |
| 5 Year Change | -96.25% |
| Change since IPO | -96.78% |
Noticias y actualizaciones recientes
Recent updates
Yourgene Health Plc (LON:YGEN) Shares Could Be 34% Above Their Intrinsic Value Estimate
Sep 22
Is There An Opportunity With Yourgene Health Plc's (LON:YGEN) 35% Undervaluation?
Apr 15We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Yourgene Health Plc's (LON:YGEN) CEO For Now
Sep 22Estimating The Intrinsic Value Of Yourgene Health Plc (LON:YGEN)
Aug 07Does This Valuation Of Yourgene Health Plc (LON:YGEN) Imply Investors Are Overpaying?
Feb 25What Did Yourgene Health's (LON:YGEN) CEO Take Home Last Year?
Jan 27What Kind Of Shareholders Hold The Majority In Yourgene Health Plc's (LON:YGEN) Shares?
Dec 22Rentabilidad de los accionistas
| YGEN | GB Medical Equipment | Mercado GB | |
|---|---|---|---|
| 7D | 1.0% | 0.4% | 0.5% |
| 1Y | -90.9% | -9.7% | 6.3% |
Rentabilidad vs. Industria: YGEN underperformed the UK Medical Equipment industry which returned -7.4% over the past year.
Rentabilidad vs. Mercado: YGEN underperformed the UK Market which returned -1.4% over the past year.
Volatilidad de los precios
| YGEN volatility | |
|---|---|
| YGEN Average Weekly Movement | 40.2% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Precio estable de las acciones: YGEN's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: YGEN's weekly volatility has increased from 25% to 40% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 253 | Lyn Rees | www.yourgene-health.com |
Resumen de fundamentos de Yourgene Health Plc
| Estadísticas fundamentales de YGEN | |
|---|---|
| Capitalización bursátil | UK£16.45m |
| Beneficios(TTM) | -UK£8.17m |
| Ingresos (TTM) | UK£29.67m |
0.6x
Ratio precio-ventas (PS)-2.0x
Ratio precio-beneficio (PE)¿Está YGEN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de YGEN | |
|---|---|
| Ingresos | UK£29.67m |
| Coste de los ingresos | UK£13.21m |
| Beneficio bruto | UK£16.46m |
| Otros gastos | UK£24.63m |
| Beneficios | -UK£8.17m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.0026 |
| Margen bruto | 55.48% |
| Margen de beneficio neto | -27.55% |
| Ratio deuda/patrimonio | 15.7% |
¿Cómo se ha desempeñado YGEN a largo plazo?
Ver rendimiento histórico y comparativa